Bell Potter Downgrades Telix Pharmaceuticals to Hold From Buy; Price Target Is AU$21.30
Analysts Conflicted on These Healthcare Names: Alcon (ALC) and Telix Pharmaceuticals Ltd. (OtherTLPPF)
Telix Pharmaceuticals Price Target Raised 1.3% to A$32.30/Share by Jefferies
Clinuvel Pharmaceuticals Price Target Cut 14% to A$39.70/Share by Jefferies
Cochlear Limited (CHEOF) Gets a Hold From Jarden
Immutep Ltd (PRRUF) Gets a Buy From Canaccord Genuity
Correct: CSL Price Target Cut 2% to A$291.78/Share by Wilsons
Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF), CSL (OtherCMXHF) and Neuren Pharmaceuticals Limited (OtherNURPF)
Neuren Pharmaceuticals Price Target Cut 11% to A$25.00/Share by Bell Potter
Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF) and American Well (AMWL)
Euroz Hartleys Adjusts Proteomics International Laboratories' Price Target to AU$1.10 From AU$2, Keeps at Speculative Buy
Analysts Are Bullish on These Healthcare Stocks: Telix Pharmaceuticals Ltd. (TLPPF), Warby Parker (WRBY)
Jefferies Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)
Bell Potter Remains a Buy on Clarity Pharmaceuticals Ltd. (CU6)
Clarity Pharmaceuticals Price Target Raised to A$10.00/Share From A$4.00 by Bell Potter
Telix Pharmaceuticals Price Target Cut 3.6% to A$31.90/Share by Jefferies
Mesoblast Price Target Raised to $11.00/Share From $4.00 by Piper Sandler
Telix Pharmaceuticals Ltd. (TLPPF) Receives a Buy From TD Cowen
Bell Potter Sticks to Its Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)
Jefferies Remains a Buy on Immutep Ltd (PRRUF)